{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T20:05:44Z","timestamp":1760385944569,"version":"3.37.3"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Dis Travel Med Vaccines"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Leishmaniasis is a vector-borne disease caused by several species from genus<jats:italic>Leishmania<\/jats:italic>. An increase in the number of cases related to human movement has been informed in the last years. Due to the increase of suspicious leishmaniasis cases arriving in Cuba during 2017, a general analysis is presented herein.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Clinical samples were collected from 5 patients suspicious of leishmaniasis, received from January to December 2017 at the Institute of Tropical Medicine Pedro Kour\u00ed, Cuba. Skin lesion samples were analyzed using different diagnostic assays: direct smear, histological examination, and molecular analysis for species identification. Epidemiological and demographic data were requested from each case and analyzed. Treatment and follow up of patient was also performed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Five cases were confirmed as<jats:italic>Leishmania<\/jats:italic>infection according to microscopic observation and molecular methods results. PCR-18S, PCR-N\/RFLP and PCR-F\/RFLP identified the following species:<jats:italic>L. panamensis<\/jats:italic>(2 cases),<jats:italic>L. braziliensis<\/jats:italic>(1 case),<jats:italic>L.panamensis<\/jats:italic>\/<jats:italic>L.guyanensis<\/jats:italic>(1 case),<jats:italic>L. mexicana<\/jats:italic>complex (1 case). In treated patients, drugs were well tolerated, cure were documented and no relapse have been currently reported (3\u2009years later).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Clinical characteristics, demographic data, and epidemiological features of infection for each case evidence the potential risk related with travel to endemic areas of leishmaniasis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Keyworks<\/jats:title><jats:p>Cutaneous leishmaniasis, Epidemiology, Imported cases.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40794-022-00171-9","type":"journal-article","created":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:03:03Z","timestamp":1656633783000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Imported cases of cutaneous leishmaniasis in Cuba, 2017: role of human movement"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1958-809X","authenticated-orcid":false,"given":"Lianet","family":"Monzote","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orestes","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Cap\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Margarita","family":"Montalvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,1]]},"reference":[{"issue":"5","key":"171_CR1","doi-asserted-by":"publisher","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, V\u00e9lez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671.","journal-title":"PLoS One"},{"issue":"4","key":"171_CR2","doi-asserted-by":"publisher","first-page":"e61843","DOI":"10.1371\/journal.pone.0061843","volume":"8","author":"L Reveiz","year":"2013","unstructured":"Reveiz L, Maia-Elkhoury ANS, Nicholls RS, Sierra Romero GA, Yadon ZE. Interventions for American cutaneous and Mucocutaneous Leishmaniasis: a systematic review update. PLoS One. 2013;8(4):e61843.","journal-title":"PLoS One"},{"issue":"27","key":"171_CR3","first-page":"2","volume":"39","author":"SA Matlin","year":"2018","unstructured":"Matlin SA, Depoux SS, Flahault A, Saso L. Migrants\u2019and refugees\u2019 health: towards anagenda of solutions. Public Health Rev. 2018;39(27):2\u201355.","journal-title":"Public Health Rev"},{"issue":"10","key":"171_CR4","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1017\/S0950268818001309","volume":"146","author":"SK S\u00f6birk","year":"2018","unstructured":"S\u00f6birk SK, Inghammar M, Collin M, Davidsson L. Imported leishmaniasis in Sweden 1993\u20132016. Epidemiol Infect. 2018;146(10):1267\u201374.","journal-title":"Epidemiol Infect"},{"key":"171_CR5","doi-asserted-by":"publisher","first-page":"e6313","DOI":"10.7717\/peerj.6313","volume":"7","author":"KJ Beiter","year":"2019","unstructured":"Beiter KJ, Wentlent ZJ, Hamouda AR, Thomas BN. Nonconventional opponents: a review of malaria and leishmaniasis among United States armed forces. PeerJ. 2019;7:e6313.","journal-title":"PeerJ"},{"issue":"1","key":"171_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41597-020-0451-5","volume":"7","author":"G Herrera","year":"2020","unstructured":"Herrera G, Barrag\u00e1n N, Luna N, Mart\u00ednez D, De Martino F, Medina J, et al. An interactive database of Leishmania species distribution in the Americas. Sci Data. 2020;7(1):110.","journal-title":"Sci Data"},{"issue":"10151","key":"171_CR7","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis. Lancet. 2018;392(10151):951\u201370.","journal-title":"Lancet"},{"unstructured":"Pan American Health Organization. Leishmaniasis. Epidemiological report of the Americas. Report No. 8 (Pan American Health Organization\/World Health Organization. 2019).","key":"171_CR8"},{"key":"171_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s40794-018-0067-3","volume":"4","author":"A Montalvo","year":"2018","unstructured":"Montalvo A, Fraga J, Blanco O, Gonz\u00e1lez D, Monzote L, Soong L, et al. Imported leishmaniasis cases in Cuba (2006\u20132016). What have we learned? Trop Dis Travel Med Vaccines. 2018;4:7.","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"10","key":"171_CR10","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1086\/592509","volume":"198","author":"S Deborggraeve","year":"2008","unstructured":"Deborggraeve S, Laurent T, Espinosa D, Van der Auwera G, Mbuchi M, Wasunna M, et al. A simplified and standardized polymerase chain reaction format for the diagnosis of leishmaniasis. J Infect Dis. 2008;198(10):1565\u201372.","journal-title":"J Infect Dis"},{"issue":"7","key":"171_CR11","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1007\/s10096-011-1463-z","volume":"31","author":"AM Montalvo","year":"2012","unstructured":"Montalvo AM, Fraga J, Maes I, Dujardin JC, Van Der Auwera G. Three new sensitive and specific heat-shock protein 70 PCRs for global Leishmania species identification. Eur J Clin Microbiol Infect Dis. 2012;31(7):1453\u201361.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"171_CR12","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.diagmicrobio.2013.07.023","volume":"77","author":"J Fraga","year":"2013","unstructured":"Fraga J, Montalvo AM, Maes I, Dujardin JC, Van der Auwera G. HindII and SduI digests of heat-shock protein 70 PCR for Leishmania typing. Diagn Microbiol Infect Dis. 2013;77(3):245\u20137.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"171_CR13","volume-title":"Manual de procedimientos para vigilancia y control de las leishmaniasis en las Am\u00e9ricas","author":"PAHO","year":"2019","unstructured":"PAHO. Manual de procedimientos para vigilancia y control de las leishmaniasis en las Am\u00e9ricas. Washington, D.C.: OPS; 2019."},{"issue":"8","key":"171_CR14","doi-asserted-by":"publisher","first-page":"O528","DOI":"10.1111\/1469-0691.12487","volume":"20","author":"RA Lavergne","year":"2014","unstructured":"Lavergne RA, Iriart X, Martin-Blondel G, Chauvin P, Menard S, Fillaux J, et al. Contribution of molecular diagnosis to the management of cutaneous leishmaniasis in travellers. Clin Microbiol Infect. 2014;20(8):O528\u201330.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"171_CR15","doi-asserted-by":"crossref","first-page":"653","DOI":"10.4269\/ajtmh.16-0809","volume":"96","author":"N Harrison","year":"2017","unstructured":"Harrison N, Walochnik J, Rambasebner R, Veletky L, Lagler H, Ramharter M. Case report: progressive perforation fo nasal septum due to Leishmania major: a case of mucosal leishmaniasis in a traveler. Am J Trop Med Hyg. 2017;96(3):653\u20135.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"171_CR16","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.diagmicrobio.2012.06.010","volume":"74","author":"J Fraga","year":"2012","unstructured":"Fraga J, Veland N, Montalvo AM, Praet N, Boggild AK, Valencia BM, et al. Accurate and rapid species typing from cutaneous and mucocutaneous leishmaniasis lesions of the New World. Diagn Microbiol Infect Dis. 2012;74(2):142\u201350.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"171_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.meegid.2013.05.020","volume":"18","author":"J Fraga","year":"2013","unstructured":"Fraga J, Montalvo AM, Van der Auwera G, Maes I, Dujardin JC, Requena JM. Evolution and species discrimination according to the Leishmania heat-shock protein 20 gene. Infect Genet Evol. 2013;18:229\u201337.","journal-title":"Infect Genet Evol"},{"issue":"5","key":"171_CR18","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.trstmh.2009.12.002","volume":"104","author":"AM Montalvo","year":"2010","unstructured":"Montalvo AM, Fraga J, Montano I, Monzote L, Marin M, Van Der Auwera G, et al. Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP. Trans R Soc Trop Med Hyg. 2010;104(5):364\u20137.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"Supl.1","key":"171_CR19","first-page":"37","volume":"36","author":"AM Montalvo","year":"2016","unstructured":"Montalvo AM, Fraga J, Montano I, Monzote L, Van der Auwera G, Mar\u00edn M, et al. Identificaci\u00f3n molecular con base en el gen hsp70 de aislamientos cl\u00ednicos de Leishmania spp. en Colombia. Biom\u00e9dica. 2016;36(Supl.1):37\u201344.","journal-title":"Biom\u00e9dica"},{"issue":"7","key":"171_CR20","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1007\/s00436-017-5454-6","volume":"116","author":"AM Montalvo","year":"2017","unstructured":"Montalvo AM, Fraga J, Tirado D, Bland\u00f3n G, Alba A, Van der Auwera G, et al. Detection and identification of Leishmania spp.: application of two hsp70-based PCR-RFLP protocols to clinical samples from the New World. Parasitol Res. 2017;116(7):1843\u20138.","journal-title":"Parasitol Res"},{"issue":"1","key":"171_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41182-017-0045-x","volume":"45","author":"S Simon","year":"2017","unstructured":"Simon S, Nacher M, Carme B, Basurko C, Roger A, Adenis A, et al. Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP. Trop Med Health. 2017;45(1):5.","journal-title":"Trop Med Health"},{"issue":"7","key":"171_CR22","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3201\/eid1207.051466","volume":"12","author":"B Rotureau","year":"2006","unstructured":"Rotureau B, Joubert M, Clyti E, Djossou F, Carme B. Leishmaniasis among gold miners, French Guiana. Emerg Infect Dis. 2006;12(7):1169\u201370.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"171_CR23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1128\/JCM.44.2.468-473.2006","volume":"44","author":"B Rotureau","year":"2006","unstructured":"Rotureau B, Ravel C, Nacher M, Couppie P, Curtet I, Dedet JP, et al. Molecular epidemiology of Leishmania (Viannia) guyanensis in French Guiana. J Clin Microbiol. 2006b;44(2):468\u201373.","journal-title":"J Clin Microbiol"},{"issue":"2","key":"171_CR24","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/jtm.12089","volume":"21","author":"J Blum","year":"2014","unstructured":"Blum J, Buffet P, Visser L, Harms G, Bailey MS, Caumes E, et al. LeishMan recommendations for treatment of cutaneous and mucosal leishmaniasis in travellers, 2014. J Travel Med. 2014;21(2):116\u201329.","journal-title":"J Travel Med"},{"issue":"7","key":"171_CR25","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1073\/pnas.1117280109","volume":"109","author":"KC Gray","year":"2012","unstructured":"Gray KC, Palacios DS, Dailey I, Endo MM, Uno BE, Wilcock BC, et al. Amphotericin primarily kills yeast by simply binding ergosterol. Proc Natl Acad Sci U S A. 2012;109(7):2234\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"171_CR26","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.parint.2018.12.006","volume":"69","author":"M Keighobadi","year":"2019","unstructured":"Keighobadi M, Emami S, Fakhar M, Shokri A, Mirzaei H, Teshnizi SH. Repurposing azole antifungals into antileishmanials: novel 3-triazolylflavanones with promising in vitro antileishmanial activity against Leishmania major. Parasitol Int. 2019;69:103\u20139.","journal-title":"Parasitol Int"},{"issue":"12","key":"171_CR27","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.3390\/nano9121749","volume":"9","author":"K Saleem","year":"2019","unstructured":"Saleem K, Khursheed Z, Hano C, Anjum I, Anjum S. Applications of Nanomaterials in Leishmaniasis: a focus on recent advances and challenges. Nanomaterials. 2019;9(12):1749.","journal-title":"Nanomaterials"},{"issue":"3","key":"171_CR28","doi-asserted-by":"publisher","first-page":"761","DOI":"10.4269\/ajtmh.16-0349","volume":"97","author":"C Cincur\u00e1","year":"2017","unstructured":"Cincur\u00e1 C, de Lima CMF, Machado PRL, Oliveira-Filho J, Glesby MJ, Lessa MM, et al. Mucosal leishmaniasis: a retrospective study of 327 cases from an endemic area of Leishmania (Viannia) braziliensis. Am J Trop Med Hyg. 2017;97(3):761\u20136.","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"171_CR29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1186\/s12879-020-05529-y","volume":"20","author":"CA Correa-C\u00e1rdenas","year":"2020","unstructured":"Correa-C\u00e1rdenas CA, P\u00e9rez J, Patino LH, Ram\u00edrez JD, Duque MC, Romero Y, et al. Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis. BMC Infect Dis. 2020;20(1):938.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"171_CR30","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1186\/s12879-019-4237-3","volume":"19","author":"R Kariyawasam","year":"2019","unstructured":"Kariyawasam R, Challa P, Lau R, Boggild AK. Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre\u2122 YeastOne\u2122 YO9 platform. BMC Infect Dis. 2019;19(1):593.","journal-title":"BMC Infect Dis"},{"issue":"6","key":"171_CR31","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/S1473-3099(06)70492-3","volume":"6","author":"E Schwartz","year":"2006","unstructured":"Schwartz E, Hatz C, Blum J. New world cutaneous leishmaniasis in travellers. Lancet Infect Dis. 2006;6(6):342\u20139.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"171_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","volume":"9","author":"S Srivastava","year":"2016","unstructured":"Srivastava S, Shankar P, Mishra J, Singh S. Possibilities and challenges for developing a successful vaccine for leishmaniasis. Parasit Vectors. 2016;9(1):277.","journal-title":"Parasit Vectors"},{"issue":"1","key":"171_CR33","doi-asserted-by":"publisher","first-page":"e0007831","DOI":"10.1371\/journal.pntd.0007831","volume":"14","author":"AL Wilson","year":"2020","unstructured":"Wilson AL, Courtenay O, Kelly-Hope LA, Scott TW, Takken W, Torr SJ, et al. The importance of vector control for the control and elimination of vector-borne diseases. PLoS Negl Trop Dis. 2020;14(1):e0007831.","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"171_CR34","doi-asserted-by":"publisher","first-page":"e0005868","DOI":"10.1371\/journal.pntd.0005868","volume":"11","author":"ANS Maia-Elkhoury","year":"2017","unstructured":"Maia-Elkhoury ANS, Valadas SYOB, Puppim-Buzanovsky L, Rocha F, S\u00e1nchez-V\u00e1zquez MJ. SisLeish: a multi-country standardized information system to monitor the status of leishmaniasis in the Americas. PLoS Negl Trop Dis. 2017;11(9):e0005868.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"171_CR35","first-page":"1","volume":"69","author":"AM Montalvo","year":"2017","unstructured":"Montalvo AM, Monzote L, Leishmania y leishmaniasis. 20 a\u00f1os de estudio en el IPK, aportes y perspectivas. Rev Cubana Med Trop. 2017;69(3):1\u201319.","journal-title":"Rev Cubana Med Trop"},{"key":"171_CR36","doi-asserted-by":"publisher","first-page":"101885","DOI":"10.1016\/j.tmaid.2020.101885","volume":"38","author":"M Vandeputte","year":"2020","unstructured":"Vandeputte M, van Henten S, van Griensven J, Huits R, Van Esbroeck M, Van der Auwera G, et al. Epidemiology, clinical pattern and impact of species-specific molecular diagnosis on management of leishmaniasis in Belgium, 2010\u20132018: a retrospective study. Travel Med Infect Dis. 2020;38:101885.","journal-title":"Travel Med Infect Dis"},{"issue":"1","key":"171_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5114\/ada.2019.82830","volume":"XXXVI","author":"A Kuna","year":"2019","unstructured":"Kuna A, Gajewski M, Bykowska M, Pietkiewicz H, Olsza\u0144ski R, Myjak P. Imported cutaneous leishmaniasis: a 13-year experience of a polish tertiary center. Adv Dermatol Allergol. 2019;XXXVI(1):104\u201311.","journal-title":"Adv Dermatol Allergol"},{"key":"171_CR38","first-page":"97","volume-title":"Introducci\u00f3n de la t\u00e9cnica de la RCP ADNk (S35-S36) para el diagn\u00f3stico de la Enfermedad de Chagas en el laboratorio nacional de referencia de Parasitolog\u00eda del IPK [Master thesis in Parasitology]","author":"JP Delgado","year":"2018","unstructured":"Delgado JP. Introducci\u00f3n de la t\u00e9cnica de la RCP ADNk (S35-S36) para el diagn\u00f3stico de la Enfermedad de Chagas en el laboratorio nacional de referencia de Parasitolog\u00eda del IPK [Master thesis in Parasitology]. Institute of Tropical Medicine: Havana, Cuba; 2018. p. 97."},{"key":"171_CR39","first-page":"97","volume-title":"Paludismo importado: caracterizaci\u00f3n y riesgos asociados a la gravedad, Camag\u00fcey, 1986\u20132018. [Master thesis in Parasitology]","author":"JL L\u00f3pez","year":"2019","unstructured":"L\u00f3pez JL. Paludismo importado: caracterizaci\u00f3n y riesgos asociados a la gravedad, Camag\u00fcey, 1986\u20132018. [Master thesis in Parasitology]. Havana Cuba: Institute of Tropical Medicine; 2019. p. 97."}],"container-title":["Tropical Diseases, Travel Medicine and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-022-00171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40794-022-00171-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40794-022-00171-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T06:40:14Z","timestamp":1727505614000},"score":1,"resource":{"primary":{"URL":"https:\/\/tdtmvjournal.biomedcentral.com\/articles\/10.1186\/s40794-022-00171-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["171"],"URL":"https:\/\/doi.org\/10.1186\/s40794-022-00171-9","relation":{},"ISSN":["2055-0936"],"issn-type":[{"type":"electronic","value":"2055-0936"}],"subject":[],"published":{"date-parts":[[2022,7,1]]},"assertion":[{"value":"15 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authorization of the patient to voluntarily participate was obtained throughout the application of informed consent and expected benefits were explained to each patient. Applied protocols were approved by Institutional Ethical Committee at IPK (CEI-IPK-8918). The handling of all the data of each patient, the clinical-epidemiological record and the results, were carried out under the strictest standards of confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for the scientific\/academic use of samples and data was obtained from the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}